Usually, studying the relationship between DNA and disease involves comparing the genomes of thousands of people with a disorder to the genomes of thousands of people who don’t. These studies can be expensive and may take years, requiring researchers to identify patients, enroll them in the study, and collect the genomic data.
A more cost-effective and speedier alternative is to mine the growing pool of genetic data in electronic medical records, report researchers in Nature Biotechnology on Sunday. These records chronicle a patient’s health care history, which can include physician’s notes, lab test results, and the billing codes hospitals submit to health insurance companies to receive payments.
The idea behind the new method for genetic discover is to be able to “reuse” the data in these records for medical discoveries, says Joshua Denny, a physician-scientist at Vanderbilt University School of Medicine.
To identify previously unknown relationships between disease and DNA variants, Denny and colleagues grouped around 15,000 billing codes from medical records into 1,600 disease categories. Then, the researchers looked for associations between disease categories and DNA data available in each record.
Their biggest new findings all involved skin diseases (just a coincidence, says Josh Denny, the lead author): non melanoma skin cancer and two forms of skin growths called keratosis, one of which is pre-cancerous. The team was able to validate the connection between these conditions and their associated gene variants in other patient data.
Unlike the standard method of exploring the genetic basis of disease, electronic medical records (EMRs) allows researchers to look for genetic associations of many different diseases at once, which could lead to a better understanding of how some single genes may affect multiple characteristics or conditions. The approach may also be less biased than disease-specific studies.
The study examined 13,000 EMRs, but in the future, similar studies could look benefit from much larger data sets. While not all patient records contain the genetic data needed to drive this kind of research, that is expected to change now that DNA analysis has become faster and more affordable in recent years and more and more companies and hospitals offer genetic analysis as part of medical care. When researchers have millions of EMRs at their finger tips, more subtle and complex effects of genes on disease and health could come to light. For example, it could allow for important studies on the genetics of drug side effects, which can be rare, affecting maybe 1 in 10,000 patients, Denny says.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.